What is the recommended treatment for stomach ulcers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Stomach Ulcers

The recommended first-line treatment for stomach ulcers is a combination of proton pump inhibitor (PPI) therapy and Helicobacter pylori eradication therapy (if H. pylori positive), with standard triple therapy consisting of a PPI, clarithromycin, and amoxicillin for 14 days, followed by continued PPI therapy for a total of 4-8 weeks to ensure complete healing. 1

Diagnostic Approach

  1. Test all patients with suspected stomach ulcers for H. pylori infection using:
    • Urea breath test (sensitivity 88-95%, specificity 95-100%)
    • Stool antigen testing (sensitivity 94%, specificity 92%)
    • Endoscopic tissue biopsy (if endoscopy is performed) 1, 2

Treatment Algorithm

Step 1: H. pylori Testing and Eradication

  • All patients with stomach ulcers should be tested for H. pylori infection 2, 1

  • If H. pylori positive, initiate eradication therapy:

    For areas with low clarithromycin resistance:

    • Standard triple therapy for 14 days:
      • PPI standard dose twice daily
      • Clarithromycin 500 mg twice daily
      • Amoxicillin 1000 mg twice daily 2, 1

    For areas with high clarithromycin resistance:

    • Sequential therapy (10 days):
      • PPI standard dose twice daily + amoxicillin 1000 mg twice daily for first 5 days
      • PPI standard dose twice daily + clarithromycin 500 mg twice daily + metronidazole 500 mg twice daily for next 5 days 2, 1

    If first-line therapy fails:

    • Levofloxacin-based triple therapy (10 days):
      • PPI standard dose twice daily
      • Levofloxacin 500 mg once daily or 250 mg twice daily
      • Amoxicillin 1000 mg twice daily 2

Step 2: PPI Therapy

  • For active gastric ulcers, continue PPI therapy for 4-8 weeks total 1, 3
  • Omeprazole 20-40 mg daily is FDA-approved for short-term treatment (4-8 weeks) of active benign gastric ulcer 3
  • Studies show healing rates of 74.8% at 8 weeks with omeprazole 20 mg daily and 82.7% with omeprazole 40 mg daily 3

Step 3: NSAID Management

  • If patient is taking NSAIDs:
    • Discontinue NSAID use if possible 1
    • If continued NSAID use is necessary:
      • For moderate risk: NSAID + PPI or selective COX-2 inhibitor alone
      • For high bleeding risk: selective COX-2 inhibitor + PPI 1

Special Considerations

Bleeding Ulcers

  • For bleeding ulcers:
    • Start PPI therapy immediately 2
    • Consider pre-endoscopy erythromycin to improve visualization 2
    • After successful endoscopic hemostasis, administer high-dose PPI as continuous infusion (80 mg bolus followed by 8 mg/h) for the first 72 hours 2, 1
    • Continue PPI for 6-8 weeks following endoscopic treatment 2

Monitoring and Follow-up

  • Confirm H. pylori eradication after treatment 1
  • H. pylori eradication reduces ulcer recurrence from 50-60% to 0-2% 1
  • Long-term PPI therapy is not recommended unless ongoing NSAID use is necessary 2, 1

Efficacy of Treatment

  • Omeprazole is superior to H2-receptor antagonists in healing gastric ulcers, with healing rates of up to 100% after 4-8 weeks 4
  • For NSAID-associated ulcers, omeprazole 20 mg daily has shown higher healing rates (83% for gastric ulcers) compared to ranitidine (64%) and misoprostol (74%) 5
  • For refractory ulcers that failed H2-receptor antagonist therapy, omeprazole 40 mg daily has demonstrated a 97% healing rate 6

By following this evidence-based approach to stomach ulcer treatment, focusing on H. pylori eradication when present and appropriate PPI therapy, most patients will achieve complete ulcer healing and significant reduction in recurrence risk.

References

Guideline

Gastrointestinal Ulcer Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Omeprazole in the acute treatment of gastric ulcer.

Scandinavian journal of gastroenterology. Supplement, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.